Target Name: CADM4
NCBI ID: G199731
Review Report on CADM4 Target / Biomarker Content of Review Report on CADM4 Target / Biomarker
CADM4
Other Name(s): immunoglobulin superfamily member 4C | TSLL2 | NECL4 | nectin-like 4 | Nectin-like 4 | SynCAM4 | Immunoglobulin superfamily member 4C | Necl-4 | NECL-4 | synCAM4 | TSLC1-like protein 2 | CADM4_HUMAN | TSLC1-like 2 | cell adhesion molecule 4 | IGSF4C | Cell adhesion molecule 4 | nectin-like protein 4 | IgSF4C | Nectin-like protein 4

CADM4: A Potential Drug Target and Biomarker

CADM4 (Cadherin-associated protein 4) is a protein that is expressed in various tissues and cell types in the human body. It is a member of the cadherin family, which is a transmembrane protein that plays a critical role in cell-cell adhesion. CADM4 has been shown to be involved in many different processes in the body, including tissue repair, cell signaling, and cell proliferation.

One of the key functions of CADM4 is its role in cell-cell adhesion. cadherins are responsible for the formation of tight junctions, which are the tight, non-covalent connections that form between cells in the same tissue or in different tissues. These connections are important for many different processes in the body, including the regulation of ion and solute transport, the maintenance of tissue structure, and the control of cell signaling.

In addition to its role in cell-cell adhesion, CADM4 is also involved in many other cellular processes. For example, it has been shown to be involved in the regulation of cell cycle progression, cell apoptosis (programmed cell death), and cell migration. In addition, CADM4 has been shown to play a role in the development and maintenance of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Due to its involvement in so many different cellular processes, CADM4 has been identified as a potential drug target. Researchers are interested in using small molecules or other compounds to inhibit the activity of CADM4 and prevent it from causing harm to the body. This research is being done in order to develop new treatments for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the challenges in developing new treatments for diseases is identifying the specific target that is causing the disease. In the case of CADM4, researchers are still trying to determine exactly what the protein does and how it is involved in the development and progression of various diseases. However, research has identified a number of potential targets for CADM4, including the interaction with other proteins, the regulation of cellular signaling pathways, and the control of cell cycle progression.

While more research is needed to fully understand the role of CADM4 in the development and progression of diseases, the potential targets for the protein are being investigated as a means of developing new treatments for a variety of diseases.

Protein Name: Cell Adhesion Molecule 4

Functions: Involved in the cell-cell adhesion. Has calcium- and magnesium-independent cell-cell adhesion activity. May have tumor-suppressor activity

The "CADM4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CADM4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CADPS | CADPS2 | CAGE1 | CAHM | CALB1 | CALB2 | CALCA | CALCB | Calcium channel | Calcium release-activated channel (CRAC) | Calcium-activated chloride channel regulators | Calcium-Activated K(Ca) Potassium Channel | CALCOCO1 | CALCOCO2 | CALCR | CALCRL | CALCRL-AS1 | CALD1 | CALHM1 | CALHM2 | CALHM3 | CALHM4 | CALHM5 | CALHM6 | CALM1 | CALM2 | CALM2P1 | CALM2P2 | CALM3 | CALML3 | CALML3-AS1 | CALML4 | CALML5 | CALML6 | Calmodulin | CALN1 | Calpain | Calpain-13 | Calprotectin | CALR | CALR3 | CALU | CALY | CAMK1 | CAMK1D | CAMK1G | CAMK2A | CAMK2B | CAMK2D | CAMK2G | CAMK2N1 | CAMK2N2 | CAMK4 | CAMKK1 | CAMKK2 | CAMKMT | CAMKV | CAMLG | CAMP | cAMP Phosphodiesterase | cAMP Responsive Element Binding Protein (CREB) | cAMP-Dependent protein kinase (PKA) | CAMSAP1 | CAMSAP2 | CAMSAP3 | CAMTA1 | CAMTA2 | CAND1 | CAND1.11 | CAND2 | Cannabinoid receptor | CANT1 | CANX | Cap-binding complex | CAP1 | CAP2 | CAPG | CAPN1 | CAPN10 | CAPN10-DT | CAPN11 | CAPN12 | CAPN13 | CAPN14 | CAPN15 | CAPN2 | CAPN3 | CAPN5 | CAPN6 | CAPN7 | CAPN8 | CAPN9 | CAPNS1 | CAPNS2 | CAPRIN1 | CAPRIN2 | CAPS | CAPS2 | CAPSL | CAPZA1